[go: up one dir, main page]

BG104286A - Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients - Google Patents

Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients

Info

Publication number
BG104286A
BG104286A BG104286A BG10428600A BG104286A BG 104286 A BG104286 A BG 104286A BG 104286 A BG104286 A BG 104286A BG 10428600 A BG10428600 A BG 10428600A BG 104286 A BG104286 A BG 104286A
Authority
BG
Bulgaria
Prior art keywords
alcohol
prevention
alcoholics
withdrawal
symptoms
Prior art date
Application number
BG104286A
Other languages
Bulgarian (bg)
Other versions
BG64363B1 (en
Inventor
Aldo Fassi
Claudio Cavazza
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of BG104286A publication Critical patent/BG104286A/en
Publication of BG64363B1 publication Critical patent/BG64363B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The pharmaceutical composition contains a combination of L-carnitine, acetyl L-carnitine and propionyl L-carnitine or their pharmacologically acceptable salts. It can be also used as a dietetic additive to wholesome and medical diets or as nutritive additive for the prevention of alcohol addiction of healthy patients, in particular young people. 12 claims
BG104286A 1997-10-03 2000-03-30 Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients BG64363B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (en) 1997-10-03 1997-10-03 ASSOCIATION OF L-CARNITINE AND ALCANOYL L-CARNITINE FOR THE TREATMENT OF ALCOHOLISM

Publications (2)

Publication Number Publication Date
BG104286A true BG104286A (en) 2000-11-30
BG64363B1 BG64363B1 (en) 2004-12-30

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104286A BG64363B1 (en) 1997-10-03 2000-03-30 Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients

Country Status (27)

Country Link
US (1) US6255346B1 (en)
EP (1) EP1022960B1 (en)
JP (1) JP2001518484A (en)
KR (2) KR100560097B1 (en)
CN (1) CN1092939C (en)
AT (1) ATE220860T1 (en)
AU (1) AU730740B2 (en)
BG (1) BG64363B1 (en)
BR (1) BR9812604A (en)
CA (1) CA2305598C (en)
CZ (1) CZ291801B6 (en)
DE (1) DE69806788T2 (en)
DK (1) DK1022960T3 (en)
EA (1) EA002177B1 (en)
EE (1) EE04036B1 (en)
ES (1) ES2180200T3 (en)
HU (1) HUP0004336A3 (en)
IS (1) IS2234B (en)
IT (1) IT1295408B1 (en)
MX (1) MXPA00003232A (en)
NO (1) NO20001688L (en)
NZ (1) NZ503663A (en)
PL (1) PL189663B1 (en)
PT (1) PT1022960E (en)
SK (1) SK283384B6 (en)
UA (1) UA66807C2 (en)
WO (1) WO1999017623A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (en) * 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa COMPOSITION FOR THE PREVENTION AND TREATMENT OF TOXIC AND FUNCTIONAL DYSFUNCTIONS AND DISEASES.
ITRM20020194A1 (en) 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa USEFUL COMPOSITION TO INCREASE THE CONCENTRATION AND MOTILITY OF SPERMATOZOI AND IMPROVE THE MORPHOLOGY IN MAN.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (en) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti USE OF CARNITINE FOR THE PREVENTION AND / OR TREATMENT OF DISORDERS CAUSED BY ANDROPAUSE.
RU2300376C2 (en) * 2005-05-11 2007-06-10 МУЗ Городская клиническая больница №3 им. М.А. Подгорбунского г.Кемерово Method of treatment in alcoholic delirium
CN101766637B (en) * 2008-12-31 2012-08-29 克科 Composite for disintoxicating and sobering
CN101766717B (en) * 2008-12-31 2012-10-10 克科 Composition for disintoxicating and sobering
CN101766635B (en) * 2008-12-31 2012-10-10 克科 Composite for disintoxicating and sobering
CN101766716B (en) * 2008-12-31 2012-08-29 克科 Hangover relieving composition
CN101766672B (en) * 2008-12-31 2012-10-10 克科 Composition for anti-alcohol and sobering
CN101766715B (en) * 2008-12-31 2012-08-29 克科 Composite for disintoxicating and sobering
CN106176756A (en) * 2015-04-30 2016-12-07 刘力 The lysine five comprising chiral photo-isomerisation compound ties up medical composition and its use
WO2021211540A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (en) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti USE OF PROPIONIL L-CARNITINA FOR THE RECOVERY OF THE MUSCLE TONE IN IMMOBILIZED SUBJECTS
DE19527281A1 (en) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Food supplements
EP0776604B1 (en) * 1995-12-01 2002-01-23 Unilever N.V. Microwavable crispy bread-rolls
DK0793962T3 (en) * 1996-03-04 2000-05-22 Sigma Tau Ind Farmaceuti Medicinal product containing a carnitine derivative for the treatment of arteriosclerosis obliterans

Also Published As

Publication number Publication date
EP1022960B1 (en) 2002-07-24
KR20010030928A (en) 2001-04-16
EA002177B1 (en) 2002-02-28
CN1276704A (en) 2000-12-13
PL189663B1 (en) 2005-09-30
BR9812604A (en) 2000-08-01
SK4762000A3 (en) 2000-10-09
US6255346B1 (en) 2001-07-03
MXPA00003232A (en) 2004-03-10
DE69806788T2 (en) 2003-04-03
EE04036B1 (en) 2003-06-16
KR20050088499A (en) 2005-09-06
CZ291801B6 (en) 2003-05-14
UA66807C2 (en) 2004-06-15
CZ20001207A3 (en) 2000-11-15
NZ503663A (en) 2001-11-30
BG64363B1 (en) 2004-12-30
DK1022960T3 (en) 2002-11-04
EE200000235A (en) 2001-06-15
KR100560097B1 (en) 2006-03-13
HUP0004336A2 (en) 2001-05-28
AU730740B2 (en) 2001-03-15
EP1022960A1 (en) 2000-08-02
KR100530368B1 (en) 2005-11-22
WO1999017623A1 (en) 1999-04-15
JP2001518484A (en) 2001-10-16
SK283384B6 (en) 2003-06-03
ES2180200T3 (en) 2003-02-01
IS2234B (en) 2007-04-15
HUP0004336A3 (en) 2001-07-30
ATE220860T1 (en) 2002-08-15
CN1092939C (en) 2002-10-23
DE69806788D1 (en) 2002-08-29
AU9366098A (en) 1999-04-27
CA2305598C (en) 2007-11-20
HK1028714A1 (en) 2001-03-02
PL339621A1 (en) 2001-01-02
CA2305598A1 (en) 1999-04-15
EA200000377A1 (en) 2000-10-30
ITRM970594A1 (en) 1999-04-03
NO20001688D0 (en) 2000-03-31
PT1022960E (en) 2002-12-31
NO20001688L (en) 2000-06-02
IS5416A (en) 2000-03-24
IT1295408B1 (en) 1999-05-12

Similar Documents

Publication Publication Date Title
BG104286A (en) Composition for the suppression of the symptoms of withdrawal and irresistible desire for alcohol in alcoholics and prevention of alcohol addiction among healthy patients
WO1991011117A3 (en) Dietary supplements comprising vitamins and minerals
HK1007111B (en) Herbal compositions with reduced polysaccharide content for treatment of skin disorders
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
CA2262972A1 (en) Compositions of plant carbohydrates as dietary supplements
CA2229279A1 (en) Nutritional and/or dietary composition and method of using the same
EP0903143A3 (en) Use of daidzein for the manufacture of a medicament for incraesing HDL cholesterol levels
CA2294099A1 (en) Absorption of minerals
CA2159058A1 (en) Inhibition of helicobacter
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
NZ500532A (en) Solid compositions suitable for oral administration comprising an alkanoyl-L-carnitine magnesium citrate
WO2001028526A3 (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
ZA971134B (en) Multifunctional fat absorption and blood cholesterol reducing formulation.
WO2001026666A3 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
MX9703810A (en) Medicament comprising a carnitine derivative to treat alzheimer disease in patients with premature onset.
CA2395530A1 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
WO2000040225A3 (en) Inhibition of tnf activity
CA2291233A1 (en) Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
NZ500538A (en) Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
TR200200224T2 (en) Composition for the prevention and treatment of kidney disorders and diseases
CA2391625A1 (en) Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
AU2742395A (en) Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets
SI0975581T1 (en) Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
JP2002201135A (en) Composition for epigastrium comprising lactulose
PL312741A1 (en) Application of benidamine in treatment of pathologies caused by tnf